That is well put Ron, indeed I fully agree. I'm very grateful and lucky to have come across this space that Dr Aftab has created.
On reflection, I missed a pretty important piece of context re: toxicity in my reply, which I would like to clear up and communicate. I didn't mean to go so deep into my story - a researcher's instinct to provi…
That is well put Ron, indeed I fully agree. I'm very grateful and lucky to have come across this space that Dr Aftab has created.
On reflection, I missed a pretty important piece of context re: toxicity in my reply, which I would like to clear up and communicate. I didn't mean to go so deep into my story - a researcher's instinct to provide detail is sometimes disadvantageous!
Your original comment helped me to come to what I hope is a valid realisation. The ICI lithium page had, putting it generously, a diverse number of issues. My eye as a patient locked onto toxicity, whereas maybe a psychiatrist might lock onto something else (while in this case you were looking at my article, I could foresee a psychiatrist spotting the lack of mention of benefits of lithium on the ICI site, for instance). I was thinking this might be another potential example where the psychiatrist - patient combination would work really well together.
Thank you very much for the references on the benefits of lithium (and for digoxin and phenytoin refs, which I did not know about, shall make for some interesting reading!)
And thank you for your comments and help. I look forward to reading your comments here and the nuance you add, as well as continuing to read about your insights in your Psychiatric Times articles.
That is well put Ron, indeed I fully agree. I'm very grateful and lucky to have come across this space that Dr Aftab has created.
On reflection, I missed a pretty important piece of context re: toxicity in my reply, which I would like to clear up and communicate. I didn't mean to go so deep into my story - a researcher's instinct to provide detail is sometimes disadvantageous!
Your original comment helped me to come to what I hope is a valid realisation. The ICI lithium page had, putting it generously, a diverse number of issues. My eye as a patient locked onto toxicity, whereas maybe a psychiatrist might lock onto something else (while in this case you were looking at my article, I could foresee a psychiatrist spotting the lack of mention of benefits of lithium on the ICI site, for instance). I was thinking this might be another potential example where the psychiatrist - patient combination would work really well together.
Thank you very much for the references on the benefits of lithium (and for digoxin and phenytoin refs, which I did not know about, shall make for some interesting reading!)
And thank you for your comments and help. I look forward to reading your comments here and the nuance you add, as well as continuing to read about your insights in your Psychiatric Times articles.
All my best,
Alex